Atlas Trials

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

Clinical trial NCT00116610 · COMPLETED

Trial details

NCT number
NCT00116610
Sponsor
Poniard Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2005-06-01
Primary completion
2007-03-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.